Reinforcing apoptosis-resistance of COS and myeloma cells by transfecting with bcl-2 gene
- PMID: 22358876
- PMCID: PMC3466756
- DOI: 10.1023/A:1007935026770
Reinforcing apoptosis-resistance of COS and myeloma cells by transfecting with bcl-2 gene
Abstract
COS, myeloma and HeLa cells, which are commonly used for protein production by cell culture, were transfected with human bcl-2 gene encoded on the shuttle vector BCMGS. Expression of human bcl-2 improved survival of cells remarkably, mildly, or negligibly for COS, myeloma, and HeLa, respectively. Four clones were obtained from the human bcl-2 expressing cell population of COS cells. They expressed human bcl-2 almost at the same level. The viable cell numbers were 6, 2.5, 2.5, and 0.8 times as many for the clones #8, #5, #6, and #7, respectively, as for the control COS cells, when they were cultured at low (0.2%) serum concentration for 9 days. The bcl-2 overexpressing COS cells showed morphology different from that of the control COS cells in serum limited condition. When transfected with mouse lambda protein gene carried by an SV40-derived vector, clone #8 of the bcl-2 transfected COS cells continued the transient expression of lambda protein longer than the control COS cells.
References
-
- Ausbel FM, Brent R, Kingstone RE, Moors DD, Seidman JG, Smith JA and Struhi K (1995) Current Protocols in Molecular Biology, supplement 36 (pp. 16.13.1–7) John Wiley & Sons, Inc.
-
- Fujita T, Terada S, Ueda H, Suzuki E. Overexpression of bcl-2 improved survival of COS-1 cells and enhances transient protein production. J Fermentation and Bioengineering. 1996;82:588–590.
-
- Gauthier ER, Piche L, Lemieux G, Lemieux R. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells. Cancer Res. 1996;56:1451–1456. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources